Adaptive Biotechnologies' Series B - II Round

Adaptive Biotechnologies raised a round of funding on June 21, 2012.

Adaptive Biotechnologies, formerly Adaptive TCR, is a pioneer in immunosequencing diagnostics, with a focus in oncology. The Company leverages advances in next generation sequencing ("NGS") to profile…

Articles about Adaptive Biotechnologies' Series B - II Round: